Modelled health benefits of a sugar-sweetened beverage tax across different socioeconomic groups in Australia: A cost-effectiveness and equity analysis
Anita Lal and colleagues model for and reveal the potential health benefits and cost savings from a sugar sweetened beverage tax in Australia.
Vyšlo v časopise:
Modelled health benefits of a sugar-sweetened beverage tax across different socioeconomic groups in Australia: A cost-effectiveness and equity analysis. PLoS Med 14(6): e32767. doi:10.1371/journal.pmed.1002326
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002326
Souhrn
Anita Lal and colleagues model for and reveal the potential health benefits and cost savings from a sugar sweetened beverage tax in Australia.
Zdroje
1. Friel S, Broom D. Unequal society, unhealthy weight: the social distribution of obesity. In: Dixon J, Broom D, editors. The 7 deadly sins of obesity: how the modern world is making us fat. Sydney: University of New South Wales Press; 2007. pp. 148–72.
2. Crombie L, Irvine L, Elliott L, Wallace H. Closing the health inequalities gap: an international perspective. Copenhagen: World Health Organization Regional Office for Europe; 2005.
3. Vartanian L, Schwartz M, Brownell K. Effects of soft drink consumption on nutrition and health: a systematic review and meta-analysis. Am J Public Health. 2007;97:667–75. doi: 10.2105/AJPH.2005.083782 17329656
4. Malik V, Schulze M, Hu F. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr. 2006;84:274–88. 16895873
5. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968–77. 6219830
6. GBD 2010 Country Collaboration. GBD 2010 country results: a global public good. Lancet. 2013;381:965–70. doi: 10.1016/S0140-6736(13)60283-4 23668561
7. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–9. 12503980
8. Mullie P, Aerenhouts D, Clarys P. Demographic, socioeconomic and nutritional determinants of daily versus non-daily sugar-sweetened and artificially sweetened beverage consumption. Eur J Clin Nutr. 2012;66:150–5. doi: 10.1038/ejcn.2011.138 21829215
9. van Ansem WJ, van Lenthe FJ, Schrijvers CT, Rodenburg G, van de Mheen D. Socio-economic inequalities in children’s snack consumption and sugar-sweetened beverage consumption: the contribution of home environmental factors. Br J Nutr. 2014;112:467–76. doi: 10.1017/S0007114514001007 24833428
10. Institute of Medicine. Accelerating progress in obesity prevention: solving the weight of the nation. Washington (DC): National Academies Press; 2012.
11. National Preventative Health Taskforce. Australia: the healthiest country by 2020—national preventative health strategy—overview. Canberra: Commonwealth of Australia; 2009.
12. Brownell KD, Farley T, Willett WC, Popkin BM, Chaloupka FJ, Thompson JW, et al. The public health and economic benefits of taxing sugar-sweetened beverages. New Engl J Med. 2009;361:1599–605. doi: 10.1056/NEJMhpr0905723 19759377
13. Andreyeva T, Long MW, Brownell KD. The impact of food prices on consumption: a systematic review of research on the price elasticity of demand for food. Am J Public Health. 2010;100:216–22. doi: 10.2105/AJPH.2008.151415 20019319
14. Cabrera Escobar MA, Veerman JL, Tollman SM, Bertram MY, Hofman KJ. Evidence that a tax on sugar sweetened beverages reduces the obesity rate: a meta-analysis. BMC Public Health. 2013;13:1–10.
15. Duckett S, Swerissen H. A sugary drinks tax: recovering the community costs of obesity. Melbourne: Grattan Institute; 2016.
16. Jensen JD, Smed S. Cost-effective design of economic instruments in nutrition policy. Int J Behav Nutr Phys Act. 2007;4:10. doi: 10.1186/1479-5868-4-10 17408494
17. Colchero MA, Popkin BM, Rivera JA, Ng SW. Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: observational study. BMJ. 2016;352:h6704. doi: 10.1136/bmj.h6704 26738745
18. Colchero MA, Rivera-Dommarco J, Popkin BM, Ng SW. In Mexico, evidence of sustained consumer response two years after implementing a sugar-sweetened beverage tax. Health Aff (Millwood). 2017;36:564–71.
19. Backholer K, Sarink D, Beauchamp A, Keating C, Loh V, Ball K, et al. The impact of a tax on sugar-sweetened beverages according to socio-economic position: a systematic review of the evidence. Public Health Nutr. 2016:1–15.
20. Cobiac LJ, Tam K, Veerman L, Blakely T. Taxes and subsidies for improving diet and population health in Australia: a cost-effectiveness modelling study. PLoS Med. 2017;14:e1002232. doi: 10.1371/journal.pmed.1002232 28196089
21. Veerman JL, Sacks G, Antonopoulos N, Martin J. The impact of a tax on sugar-sweetened beverages on health and health care costs: a modelling study. PLoS ONE. 2016;11:e0151460. doi: 10.1371/journal.pone.0151460 27073855
22. World Health Organization. Fiscal policies for diet and prevention of noncommunicable diseases: technical meeting report. Geneva: World Health Organization; 2016.
23. Backholer K, Blake M, Vandevijvere S. Have we reached a tipping point for sugar-sweetened beverage taxes? Public Health Nutr. 2016;19:3057–61. doi: 10.1017/S1368980016003086 27910794
24. Australian Bureau of Statistics. Australian Health Survey 2011–12. Canberra: Australian Bureau of Statistics; 2015.
25. Murray CJ, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D, et al. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310:591–608. doi: 10.1001/jama.2013.13805 23842577
26. StataCorp. Stata Statistical Software. Release 14. College Station (Texas): StataCorp; 2015.
27. Australian Bureau of Statistics. Deciles. http://www.abs.gov.au/websitedbs/censushome.nsf/home/seifatbdeciles?opendocument&navpos=260. Accessed 8 Nov 2016.
28. Sharma A, Hauck K, Hollingsworth B, Siciliani L. The effects of taxing sugar-sweetened beverages across different income groups. Health Econ. 2014;23:1159–84. doi: 10.1002/hec.3070 24895084
29. Food Standards Australia and New Zealand. NUTTAB 2010 online searchable database. http://www.foodstandards.gov.au/science/monitoringnutrients/nutrientables/nuttab/Pages/default.aspx. Accessed 15 Nov 2016.
30. Hall KD, Sacks G, Chandramohan D, Chow CC, Wang YC, Gortmaker SL, et al. Quantification of the effect of energy imbalance on bodyweight. Lancet. 2011;378:826–37. doi: 10.1016/S0140-6736(11)60812-X 21872751
31. Hall KD, Butte NF, Swinburn BA, Chow CC. Dynamics of childhood growth and obesity: development and validation of a quantitative mathematical model. Lancet Diabetes Endocrinol. 2013;1:97–105. 24349967
32. Carter R, Moodie M, Markwick A, Magnus A, Vos T, Swinburn B, et al. Assessing cost-effectiveness in obesity (ACE-obesity): an overview of the ACE approach, economic methods and cost results. BMC Public Health. 2009;9:419. doi: 10.1186/1471-2458-9-419 19922625
33. Vos T, Carter R, Doran C, Anderson I, Lopez A, Wilson A. Assessing cost-effectiveness in the prevention of non-communicable disease (ACE-Prevention) project 2005–09: economic evaluation protocol (as per September 2007). Brisbane: University of Queensland; 2007.
34. Lee YY, Veerman JL, Barendregt JJ. The cost-effectiveness of laparoscopic adjustable gastric banding in the morbidly obese adult population of Australia. PLoS ONE. 2013;8:e64965. doi: 10.1371/journal.pone.0064965 23717680
35. Cobiac L, Vos T, Veerman L. Cost-effectiveness of Weight Watchers and the Lighten Up to a Healthy Lifestyle program. Aust N Z J Public Health. 2010;34:240–7. doi: 10.1111/j.1753-6405.2010.00520.x 20618263
36. Veerman JL, Barendregt JJ, Forster M, Vos T. Cost-effectiveness of pharmacotherapy to reduce obesity. PLoS ONE. 2011;6:e26051. doi: 10.1371/journal.pone.0026051 22046255
37. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A. The burden of disease and injury in Australia 2003. Canberra: Australian Institute of Health and Welfare; 2007.
38. Australian Institute of Health and Welfare. Cardiovascular disease by populations of interest. Canberra: Australian Institute of Health and Welfare; 2012.
39. Australian Institute of Health and Welfare. Cancer in Australia: an overview 2014. Canberra: Australian Institute of Health and Welfare; 2014.
40. Australian Institute of Health and Welfare. Incidence of insulin-treated diabetes in Australia 2000–2011. Canberra: Australian Institute of Health and Welfare; 2014.
41. Australian Institute of Health and Welfare. Supplementary data for mortality inequalities in Australia 2009–2011. Canberra: Australian Institute of Health and Welfare; 2014.
42. Australian Bureau of Statistics. Australian Health Survey: updated results, 2011–12. Canberra: Australian Bureau of Statistics; 2013.
43. Australian Bureau of Statistics. 2011 census of population and housing. Canberra: Australian Bureau of Statistics; 2012.
44. Chen G, Ratcliffe J, Olds T, Magarey A, Jones M, Leslie E. BMI, health behaviors, and quality of life in children and adolescents: a school-based study. Pediatrics. 2014;133:e868–74. doi: 10.1542/peds.2013-0622 24590749
45. Long MW, Gortmaker SL, Ward ZJ, Resch SC, Moodie ML, Sacks G, et al. Cost effectiveness of a sugar-sweetened beverage excise tax in the U.S.. Am J Prev Med. 2015;49:112–23. doi: 10.1016/j.amepre.2015.03.004 26094232
46. Department of Health. Post-implementation review tobacco plain packaging. Canberra: Department of Health; 2016.
47. Wilson N, Nghiem N, Foster R, Cobiac L, Blakely T. Estimating the cost of new public health legislation. Bull World Health Organ. 2012;90:477–556.
48. Australian Institute of Health and Welfare. Disease Costs and Impact Study. Canberra: Australian Institute of Health and Welfare; 2001.
49. Australian Institute of Health and Welfare. Health expenditure Australia 2010–11. Canberra: Australian Institute of Health and Welfare; 2012.
50. Yusuf F, Leeder SR. Can’t escape it: the out-of-pocket cost of health care in Australia. Med J Aust. 2013;199:475–8. 24099208
51. Gold M, Siegel J, Russell L, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
52. Ersatz. Version 1.3. Noosa: EpiGear; 2016.
53. Australian Bureau of Statistics. 6348.0—labour costs, Australia, 2010–11. Canberra: Australian Bureau of Statistics; 2012.
54. Kakwani N, Wagstaff A, van Doorslaer E. Socioeconomic inequalities in health: Measurement, computation, and statistical inference. J Econom. 1997;77:87–103.
55. Euromonitor International. Soft drinks in Australia. Sydney: Euromonitor International; 2016.
56. Ni Mhurchu C, Eyles H, Schilling C, Yang Q, Kaye-Blake W, Genç M, et al. Food prices and consumer demand: differences across income levels and ethnic groups. PLoS ONE. 2013;8:e75934. doi: 10.1371/journal.pone.0075934 24098408
57. Tate DF, Turner-McGrievy G, Lyons E, Stevens J, Erickson K, Polzien K, et al. Replacing caloric beverages with water or diet beverages for weight loss in adults: main results of the Choose Healthy Options Consciously Everyday (CHOICE) randomized clinical trial. Am J Clin Nutr. 2012;95:555–63. doi: 10.3945/ajcn.111.026278 22301929
58. Colchero MA, Salgado JC, Unar-Munguia M, Hernandez-Avila M, Rivera-Dommarco JA. Price elasticity of the demand for sugar sweetened beverages and soft drinks in Mexico. Econ Hum Biol. 2015;19:129–37. doi: 10.1016/j.ehb.2015.08.007 26386463
59. Doetinchem O. Hypothecation of tax revenue for health. Geneva: World Health Organization; 2010.
60. Morley B, Martin J, Niven P, Wakefield M. Public opinion on food-related obesity prevention policy initiatives. Health Promot J Austr. 2012;23:86–91. 23088483
61. Martin J, Morley B, Niven B. Sugar-sweetened beverage (SSB) tax: framing the message for public acceptability. Behavioural Research in Cancer Control Conference 2015; 12–15 May 2015; Sydney, Australia.
62. VicHealth. Victoria’s citizens’ jury on obesity. Melbourne: VicHealth; 2015.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2017 Číslo 6
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide
- Vaccination to prevent human papillomavirus infections: From promise to practice
- A Collection on the prevention, diagnosis, and treatment of sexually transmitted infections: Call for research papers
- Elimination of mother-to-child transmission of HIV and Syphilis (EMTCT): Process, progress, and program integration